Allergan Plc Profile



Odds of Distress

Equity ratings for Allergan Plc are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 14, 2019 and ending today December 13, 2019. Please note, there could be an existing legal relationship between Allergan Plc (AGN) and AdvisorShares Vice ETF (ACT). Click here to learn more.

Allergan Plc Profile

Next fiscal quarter end is expected on December 31, 2019. The stock is in a buyout trend. Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland. Allergan Plc operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange. It employs 16900 people. more
Allergan Plc Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Allergan Plc SEC Filings
Allergan Plc SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAllergan Plc
ChairmanBrenton SaundersView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - General
InstrumentUSA Stock View All
Business AddressClonshaugh Business and Technology Park
ExchangeBATS Exchange
IndustryDrug Manufacturers?General
Phone862 261 7000
Related EntityACT
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Allergan Plc (AGN) is traded on BATS Exchange in USA. It is located in Clonshaugh Business and Technology Park and employs 16,900 people. Allergan Plc is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 54.75 B. Allergan Plc runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 328.1 M outstanding shares of which 10.68 M shares are presently shorted by investors with about 4.48 days to cover shorted positions. ALLERGAN INC has about 1.97 B in cash with 4.3 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.02.
Check Allergan Plc Probability Of Bankruptcy

Ownership Allocation (%)

Allergan Plc Target Price Odds Analysis

Odds Below 188.41HorizonTargetOdds Above 188.41
94.88%30 days 188.41 5.05%
Based on normal probability distribution, the odds of Allergan Plc to move above current price in 30 days from now is about 5.05 (This Allergan Plc probability density function shows the probability of Allergan Plc Stock to fall within a particular range of prices over 30 days) .

Allergan Plc Top Holders

Allergan Plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Allergan Plc Key Fundamentals

Allergan Plc Against Markets

Did you try this?

Run Focused Opportunities Now


Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Allergan Plc Upcoming and Recent Events

Allergan Plc Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 4, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 4, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Allergan Plc Corporate Filings

Allergan Plc SEC Reporting

Financial Statements and Exhibits. Results of Operations and Financial Condition
Submission of Matters to a Vote of Security Holders
Other Events
Unclassified Corporate Event

Allergan Plc Distributions to stockholders

Allergan Plc Corporate Directors

Ronald Taylor Independent Director
Adriane Brown Independent Director
Robert Hugin Independent Director
Check also Trending Equities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.